SCHEMBL8743

SCHEMBL8743

COc1ccc(CNc2nc3ccc(Br)cc3cc2CC(CC2CCCCC2)C(N)=O)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 1/20 0.37
CPB2 Q96IY4 1/20 0.37
CTSD P07339 4/20 0.37
MAPT P10636 3/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BACE1 P56817 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
TP53 P04637 2/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
VCP P55072 1/20 0.35
EPHX2 P34913 1/20 0.35
PPM1D O15297 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9716 0.86 BACE1 (0.37) ALDH1A1KMT2ACPB2CTSDBACE1
SCHEMBL9169 0.85 BACE1 (0.45) MAPTBACE1TP53VCP
SCHEMBL11263 0.85 HIF1A (0.36) ALDH1A1KMT2ACPB2MAPTNPC1
SCHEMBL14321942 0.80 BACE1 (0.49) ALDH1A1KMT2AMAPTNPC1RAB9A
SCHEMBL13960 0.78 MAPT (0.43) KMT2AMAPTNPC1RAB9ATDP1
SCHEMBL14322549 0.75 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTNPC1RAB9A
SCHEMBL14322551 0.75 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTNPC1RAB9A
SCHEMBL9381 0.70 KMT2A (0.48) ALDH1A1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL9314 0.70 MEN1 (0.48) KMT2AMAPTNPC1RAB9ATDP1
SCHEMBL2278793 0.69 MEN1 (0.50) KMT2AMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2504315-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2012-10-03 EP disclosed
WO-2011063233-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2011-05-26 WO disclosed